Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
28.72
+1.23 (4.47%)
Nov 2, 2026, 3:00 PM CST

SHA:603882 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
279.92-173.24-381.24643.382,7552,220
Depreciation & Amortization
399.82404.59554.03571528.4425.98
Other Amortization
102.8898.1298.4107.5790.46107.99
Loss (Gain) From Sale of Assets
-4.4-4.4-6.36-2.2-3.999.74
Asset Writedown & Restructuring Costs
12.5112.63149.969.771.020.37
Loss (Gain) From Sale of Investments
-0.21-0.21140.82-262.9710.87.29
Provision & Write-off of Bad Debts
370.99369.89618.94488.41255.3171.09
Other Operating Activities
-526.739.82-15.0214.13105.32172.8
Change in Accounts Receivable
742.6742.6263.521,247-2,702-2,116
Change in Inventory
12.2112.2149.89157.42-58.82-107.02
Change in Accounts Payable
-193.55-193.55-413.54-1,633891.851,162
Change in Other Net Operating Assets
---33.19-40.89102.14133.14
Operating Cash Flow
1,1201,202906.351,2311,9482,088
Operating Cash Flow Growth
-11.59%32.62%-26.36%-36.81%-6.71%37.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-464.5-423.46-446.36-714.75-840.54-952.42
Sale of Property, Plant & Equipment
20.1919.6315.218.9420.3773.23
Cash Acquisitions
----6.7-22.09-
Divestitures
---218.03--
Investment in Securities
-37.3121.72-25.88-150.29-8.52-131.98
Other Investing Activities
8.7311.131.510.232.411.55
Investing Cash Flow
-472.88-370.97-455.53-634.53-848.37-1,010

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-221.89368.84206.2680-
Long-Term Debt Repaid
--181.96-219.76-330.43-295.51-187.63
Lease Payments
-94.47-94.47-121.13-126.34-116.36-105.9
Net Debt Issued (Repaid)
-53.8839.93149.08-124.16-215.51-187.63
Issuance of Common Stock
26.84--41.7636.63342.13
Repurchase of Common Stock
---210-89.99--
Common Dividends Paid
-415.52-413.9-419.57-839.33-609.52-169.98
Other Financing Activities
-220.37-20.23-8.31-50.29-80.17-37.54
Financing Cash Flow
-662.92-394.2-488.8-1,062-868.57-53.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-31.26-13.5510.837.3938.95-11.46
Net Cash Flow
-47.46423.28-27.15-458.34269.861,014

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
655.1778.55459.99516.071,1071,136
Free Cash Flow Growth
-25.16%69.26%-10.87%-53.39%-2.49%16.77%
Free Cash Flow Margin
11.11%12.91%6.40%6.04%7.16%9.51%
Free Cash Flow Per Share
1.421.660.991.112.372.44
Levered Free Cash Flow
499.26852.16530.61292.07284.4502.44
Unlevered Free Cash Flow
501.22861.34542.13304.82299.18519.66
Free Cash Flow After Leases
560.64684.09338.85389.74990.951,030

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
132.4679.71182.67392.94587.14294.69
Change in Working Capital
484.82484.82-253.18-338.27-1,794-926.93